These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 33480172)

  • 1. MarkVCID cerebral small vessel consortium: I. Enrollment, clinical, fluid protocols.
    Wilcock D; Jicha G; Blacker D; Albert MS; D'Orazio LM; Elahi FM; Fornage M; Hinman JD; Knoefel J; Kramer J; Kryscio RJ; Lamar M; Moghekar A; Prestopnik J; Ringman JM; Rosenberg G; Sagare A; Satizabal CL; Schneider J; Seshadri S; Sur S; Tracy RP; Yasar S; Williams V; Singh H; Mazina L; Helmer KG; Corriveau RA; Schwab K; Kivisäkk P; Greenberg SM;
    Alzheimers Dement; 2021 Apr; 17(4):704-715. PubMed ID: 33480172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MarkVCID cerebral small vessel consortium: II. Neuroimaging protocols.
    Lu H; Kashani AH; Arfanakis K; Caprihan A; DeCarli C; Gold BT; Li Y; Maillard P; Satizabal CL; Stables L; Wang DJJ; Corriveau RA; Singh H; Smith EE; Fischl B; van der Kouwe A; Schwab K; Helmer KG; Greenberg SM;
    Alzheimers Dement; 2021 Apr; 17(4):716-725. PubMed ID: 33480157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithrombotic therapy to prevent cognitive decline in people with small vessel disease on neuroimaging but without dementia.
    Kwan J; Hafdi M; Chiang LLW; Myint PK; Wong LS; Quinn TJ
    Cochrane Database Syst Rev; 2022 Jul; 7(7):CD012269. PubMed ID: 35833913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).
    Ritchie C; Smailagic N; Noel-Storr AH; Takwoingi Y; Flicker L; Mason SE; McShane R
    Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD008782. PubMed ID: 24913723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The AlzMatch Pilot Study - Feasibility of Remote Blood Collection of Plasma Biomarkers for Preclinical Alzheimer's Disease Trials.
    Walter S; Langford O; Jimenez-Maggiora GA; Abdel-Latif S; Rissman RA; Grill JD; Karlawish J; Atri A; Bruschi S; Hussen K; Donohue MC; Marshall GA; Jicha G; Racke M; Turner RS; van Dyck CH; Venkatesh V; Yarasheski KE; Sperling R; Cummings J; Aisen PS; Raman R
    J Prev Alzheimers Dis; 2024; 11(5):1435-1444. PubMed ID: 39350391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Instrumental validation of free water, peak-width of skeletonized mean diffusivity, and white matter hyperintensities: MarkVCID neuroimaging kits.
    Maillard P; Lu H; Arfanakis K; Gold BT; Bauer CE; Zachariou V; Stables L; Wang DJJ; Jann K; Seshadri S; Duering M; Hillmer LJ; Rosenberg GA; Snoussi H; Sepehrband F; Habes M; Singh B; Kramer JH; Corriveau RA; Singh H; Schwab K; Helmer KG; Greenberg SM; Caprihan A; DeCarli C; Satizabal CL;
    Alzheimers Dement (Amst); 2022; 14(1):e12261. PubMed ID: 35382232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].
    ; ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2024 Feb; 47(2):101-119. PubMed ID: 38309959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-Site Cross-Site Inter-Rater and Test-Retest Reliability and Construct Validity of the MarkVCID White Matter Hyperintensity Growth and Regression Protocol.
    Bahrani AA; Abner EL; DeCarli CS; Barber JM; Sutton AC; Maillard P; Sandoval F; Arfanakis K; Yang YC; Evia AM; Schneider JA; Habes M; Franklin CG; Seshadri S; Satizabal CL; Caprihan A; Thompson JF; Rosenberg GA; Wang DJJ; Jann K; Zhao C; Lu H; Rosenberg PB; Albert MS; Ali DG; Singh H; Schwab K; Greenberg SM; Helmer KG; Powel DK; Gold BT; Goldstein LB; Wilcock DM; Jicha GA
    J Alzheimers Dis; 2023; 96(2):683-693. PubMed ID: 37840499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrovascular reactivity MRI as a biomarker for cerebral small vessel disease-related cognitive decline: Multi-site validation in the MarkVCID Consortium.
    Liu P; Lin Z; Hazel K; Pottanat G; Xu C; Jiang D; Pillai JJ; Lucke E; Bauer CE; Gold BT; Greenberg SM; Helmer KG; Jann K; Jicha G; Kramer J; Maillard P; Mulavelil RM; Rodriguez P; Satizabal CL; Schwab K; Seshadri S; Singh H; Velarde Dediós ÁG; Wang DJJ; Kalyani RR; Moghekar A; Rosenberg PB; Yasar S; Albert M; Lu H
    Alzheimers Dement; 2024 Aug; 20(8):5281-5289. PubMed ID: 38951718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Cerebral Blood Flow Measured by 3D PCASL as Biomarker of Vascular Cognitive Impairment and Dementia (VCID) in a Cohort of Elderly Latinx Subjects at Risk of Small Vessel Disease.
    Jann K; Shao X; Ma SJ; Cen SY; D'Orazio L; Barisano G; Yan L; Casey M; Lamas J; Staffaroni AM; Kramer JH; Ringman JM; Wang DJJ
    Front Neurosci; 2021; 15():627627. PubMed ID: 33584191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of summer programmes on the outcomes of disadvantaged or 'at risk' young people: A systematic review.
    Muir D; Orlando C; Newton B
    Campbell Syst Rev; 2024 Jun; 20(2):e1406. PubMed ID: 38873396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effectiveness of Integrated Care Pathways for Adults and Children in Health Care Settings: A Systematic Review.
    Allen D; Gillen E; Rixson L
    JBI Libr Syst Rev; 2009; 7(3):80-129. PubMed ID: 27820426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).
    Ritchie C; Smailagic N; Noel-Storr AH; Ukoumunne O; Ladds EC; Martin S
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD010803. PubMed ID: 28328043
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.